title: CREB and leukemogenesis.
abstract: Acute myeloid leukemia (AML) is one of the most common leukemias with a 20% 5-year event-free survival in adults and 50% overall survival in children, despite aggressive chemotherapy treatment and bone marrow transplantation. The incidence and mortality rates for acute leukemia have only slightly decreased over the last 20 years, and therefore greater understanding of the molecular mechanisms associated with leukemic progression is needed. To this end, a number of transcription factors that appear to play a central role in leukemogenesis are being investigated; among them is the cAMP response element binding protein (CREB). CREB is a transcription factor that can regulate downstream targets involving in various cellular functions including cell proliferation, survival, and differentiation. In several studies, the majority of bone marrow samples from patients with acute lymphoid and myeloid leukemia demonstrate CREB overexpression. Moreover, CREB overexpression is associated with a poor outcome in AML patients. This review summarizes the role of CREB in leukemogenesis.
authors.affiliation: Division of Hematology/Oncology, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-1752, USA.
authors.forename: Er-Chieh
authors.initials: EC
authors.lastname: Cho
authors.forename: Bryan
authors.initials: B
authors.lastname: Mitton
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Sakamoto
mesh_terms: D050882:CREB-Binding Protein / Q000235:genetics / Q000502:physiology*; D018450:Disease Progression; D006410:Hematopoiesis / Q000502:physiology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000503:physiopathology*; D035683:MicroRNAs / Q000235:genetics; D010766:Phosphorylation
chemical_list: D035683:MicroRNAs; D050882:CREB-Binding Protein; C494363:CREBBP protein, human